Finch Therapeutics Group Statistics
Total Valuation
FNCH has a market cap or net worth of $2.20 million. The enterprise value is $11.00 million.
| Market Cap | 2.20M |
| Enterprise Value | 11.00M |
Important Dates
The last earnings date was Friday, May 10, 2024, before market open.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FNCH has 1.61 million shares outstanding. The number of shares has increased by 0.18% in one year.
| Shares Outstanding | 1.61M |
| Shares Change (YoY) | +0.18% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 53.46% |
| Owned by Institutions (%) | 11.35% |
| Float | 891,857 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.77 |
| Forward PS | n/a |
| PB Ratio | 0.12 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.05, with a Debt / Equity ratio of 1.55.
| Current Ratio | 6.05 |
| Quick Ratio | n/a |
| Debt / Equity | 1.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0.24 |
Financial Efficiency
Return on equity (ROE) is -85.53% and return on invested capital (ROIC) is -48.37%.
| Return on Equity (ROE) | -85.53% |
| Return on Assets (ROA) | -32.51% |
| Return on Capital (ROIC) | -48.37% |
| Revenue Per Employee | $2.85M |
| Profits Per Employee | -$16.28M |
| Employee Count | 1 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.38% in the last 52 weeks. The beta is 0.26, so FNCH's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -84.38% |
| 50-Day Moving Average | 1.74 |
| 200-Day Moving Average | 3.02 |
| Relative Strength Index (RSI) | 44.82 |
| Average Volume (20 Days) | 4,759 |
Short Selling Information
The latest short interest is 19,195, so 1.20% of the outstanding shares have been sold short.
| Short Interest | 19,195 |
| Short Previous Month | 26,349 |
| Short % of Shares Out | 1.20% |
| Short % of Float | 2.15% |
| Short Ratio (days to cover) | 0.19 |
Income Statement
In the last 12 months, FNCH had revenue of $2.85 million and -$16.28 million in losses. Loss per share was -$10.14.
| Revenue | 2.85M |
| Gross Profit | 2.65M |
| Operating Income | -23.51M |
| Pretax Income | -16.28M |
| Net Income | -16.28M |
| EBITDA | -23.27M |
| EBIT | -23.46M |
| Loss Per Share | -$10.14 |
Balance Sheet
The company has $20.76 million in cash and $29.56 million in debt, giving a net cash position of -$8.80 million or -$5.48 per share.
| Cash & Cash Equivalents | 20.76M |
| Total Debt | 29.56M |
| Net Cash | -8.80M |
| Net Cash Per Share | -$5.48 |
| Equity (Book Value) | 19.04M |
| Book Value Per Share | 11.86 |
| Working Capital | 17.68M |
Cash Flow
In the last 12 months, operating cash flow was -$22.49 million and capital expenditures $14,000, giving a free cash flow of -$22.47 million.
| Operating Cash Flow | -22.49M |
| Capital Expenditures | 14,000 |
| Free Cash Flow | -22.47M |
| FCF Per Share | -$13.99 |
Margins
Gross margin is 93.11%, with operating and profit margins of -826.26% and -572.34%.
| Gross Margin | 93.11% |
| Operating Margin | -826.26% |
| Pretax Margin | -572.34% |
| Profit Margin | -572.34% |
| EBITDA Margin | -817.82% |
| EBIT Margin | -824.71% |
| FCF Margin | -789.88% |
Dividends & Yields
FNCH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.18% |
| Shareholder Yield | -0.18% |
| Earnings Yield | -740.17% |
| FCF Yield | -1,021.51% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 12, 2023. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 12, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
FNCH has an Altman Z-Score of -10.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.92 |
| Piotroski F-Score | 4 |